Entera Bio ENTX shares have rallied about 34.5% over the past month, driven by investor optimism after the company received ...

Global oncology firm Nuvation Bio Inc. NUVB on Monday revealed updated long-term data from a mid-stage trial evaluating ...

The biotech's Phase 2a study of bempikibart showed a 35.3% mean reduction in hair loss scores, with the company planning a ...

A Phase 2a clinical study of Q32 Bio's investigational antibody treatment, bempikibart, in patients with severe or very ...

Sell QTTB now. The Phase 2a headline is strong, but the stock is already up ~81% and nearly 6x YTD, with RSI in the ...

On Thursday, Tevogen Bio Holdings Inc. (NASDAQ:TVGN) announced its top-line revenue forecast for its oncology pipeline, projecting $1 billion in revenue in its launch year and a cumulative 5-year ...

Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

Gossamer Bio is back in focus after its fair value estimate was trimmed from $4.46 to $3.86, a shift that has caught the attention of investors tracking the stock. The change sits alongside mixed ...